NEW YORK (GenomeWeb) – UK synthetic biology center SynbiCITE has awarded £50,000 ($62,805) to a collaboration between LGC and Desktop Genetics to develop screening and validation tools for functional genomics, cell line engineering, and synthetic bio.

Under the partnership, Desktop Genetics and LGC will develop a new pipeline for assessing the efficiency of CRISPR-based genome editing, including two PCR-based methods and one sequencing-based method for analyzing genomic DNA. Ultimately, the collaboration will produce a protocol for detecting and quantifying targeted mutations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

ScienceInsider reports that a new security policy at the US Food and Drug Administration may prevent foreign nationals from working there.

WBUR in Boston looks into Orig3n's genetic fitness assessments to find more research is needed.

Cleveland.com reports that getting a DNA profile removed from a law enforcement database can be tricky.

In PNAS this week: de novo mutations contribute to non-syndromic craniosynostosis, fungal tree of life, and more.